Transitional cell carcinoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
== Laboratory Findings == | ==Laboratory Findings== | ||
* [[Urinalysis]]<ref name=NIH>Bladder Cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/bladder/diagnosis/?region=ab#urinetest Accessed on October, 6 2015 </ref> | |||
* | :* Blood in the urine | ||
*Bladder | * Urine cytology | ||
* | :* Abnormal cells in the urine | ||
* | * [[Tumor marker]] tests | ||
* | :* Bladder tumor–associated antigen (BTA) | ||
* | :* Nuclear matrix proteins (NMP) | ||
* | :* [[Mucin]] and [[carcinoembryonic antigen]] (CEA) | ||
* [[Complete blood count]] | |||
:* Low [[red blood cell]] count | |||
* [[Blood chemistry tests]] | |||
:* Elevated [[alkaline phosphatase]] | |||
==References== | ==References== | ||
Revision as of 21:35, 24 February 2016
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma laboratory findings |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
- Blood in the urine
- Urine cytology
- Abnormal cells in the urine
- Tumor marker tests
- Bladder tumor–associated antigen (BTA)
- Nuclear matrix proteins (NMP)
- Mucin and carcinoembryonic antigen (CEA)
- Low red blood cell count
- Elevated alkaline phosphatase
References
- ↑ Bladder Cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/bladder/diagnosis/?region=ab#urinetest Accessed on October, 6 2015